Wei Wen Kelvin Chen - 16 May 2023 Form 4 Insider Report for EUDA Health Holdings Ltd (EUDA)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
/s/ Wei Wen Kelvin Chen
Issuer symbol
EUDA
Transactions as of
16 May 2023
Net transactions value
$0
Form type
4
Filing time
26 May 2023, 08:42:17 UTC
Previous filing
25 Nov 2022
Next filing
20 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EUDA Ordinary Share Other +850,306 850,306 16 May 2023 Direct F2, F3
holding EUDA Ordinary Share 1,073,333 16 May 2023 See Footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares are owned and acquired indirectly in connection with the business combination (as disclosed in the Issuer's Current Report on Form 8-K filed on November 23, 2022) through beneficial ownership of Watermark Development Limited.
F2 The Reporting Person acquired 850,306 ordinary shares of the Issuer pursuant to certain settlement agreement between the Issuer and the Reporting Person, dated May 16, 2023.
F3 Pursuant to the Settlement Agreement referenced in footnote 2, the reported shares were issued to the Reporting Person in full satisfaction of his claim against Kent Ridge Healthcare Singapore Ltd, a wholly-owned subsidiary of the Issuer, in the amount of $850,306 (which is approximately S$1,136,264.46 at a USD/SGD exchange rate of 1 to 1.3363).